TITLE

Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori

PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study which examines the effect of lansoprazole in treating dyspepsia without Helicobacter pylori. Here, the researchers use randomized placebo-controlled trial for the young dyspeptic patients. Study shows that lansoprazole did not reduce dyspepsia or enhance quality of life in the patients without Helicobacter pylori.
ACCESSION #
28694434

 

Related Articles

  • COMMENTARY: Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori. Talley, Nicholas J. // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p10 

    The author comments on the study which examines the effect of lansoprazole in treating dyspepsia without Helicobacter pylori. Study shows that lansoprazole did not reduce dyspepsia or enhance quality of life in the patients without Helicobacter pylori. The author indicates that high rates of...

  • Successful H. pylori eradication ups QOL in functional dyspepsia.  // PharmacoEconomics & Outcomes News;12/17/2005, Issue 493, p17 

    The article focuses on a study on the role of successful Helicobacter pylori eradication in improving the quality of life in patients with functional dyspepsia, particularly those patients with ulcer-like and dysmotility-like dyspepsia. It describes a standard eradication triple therapy with...

  • One-day drug regimen for H pylori is effective. Polak, Monika // GP: General Practitioner;10/13/2003, p4 

    One-day quadruple therapy for Helicobacter pylori is as effective as the standard seven-day triple drug regimen, according to a U.S. research. Researchers randomly assigned 160 patients with dyspepsia, who had a positive urea breath test, to one of two groups. The researchers found that both...

  • Impact of Helicopter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial. Lane, J. Athene; Murray, Liam J.; Noble, Sian; Egger, Matthias; Harvey, Ian M.; Donovan, Jenny L.; Nair, Prakash; Harvey, Richard F. // BMJ: British Medical Journal (International Edition);1/28/2006, Vol. 332 Issue 7535, p199 

    Objective To determine the impact of a community based Helicobacter pylori screening and eradication programme on the incidence of dyspepsia, resource use, and quality of life, including a cost consequences analysis. Design H pylori screening programme followed by randomised placebo controlled...

  • Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia: Results of Two Randomized, Controlled Trials. Vakil, Nimish; Laine, Loren; Talley, Nicholas J.; Zakko, Salam F.; Tack, Jan; Chey, William D.; Kralstein, Jeffrey; Earnest, David L.; Ligozio, Gregory; Cohard-Radice, Marielle // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p1906 

    OBJECTIVES: Therapies for dysmotility-like functional dyspepsia (FD) are limited. We studied tegaserod, a selective serotonin type 4 receptor agonist, in patients with FD. METHODS: Two identical multicenter, double-blind, randomized, placebo-controlled trials enrolled women ≥18 yr with...

  • Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. Veldhuyzen van Zanten, Sander; Fedorak, Richard N.; Lambert, Jean; Cohen, Lawrence; Vanjaka, Anita // American Journal of Gastroenterology;Sep2003, Vol. 98 Issue 9, p1963 

    : ObjectivesThe aim of this study was to compare the effect of a combination of lansoprazole, clarithromycin, and amoxicillin (LCA) versus placebo on the severity of symptoms in functional dyspepsia patients who were positive for Helicobacter pylori (H. pylori).: MethodsThis was a double-blind,...

  • H. pylori eradication reduces dyspepsia burden but at a price.  // PharmacoEconomics & Outcomes News;3/11/2006, Issue 498, p5 

    Discusses research being done on the impact of Helicobacter pylori eradication on dyspepsia, health resource use and quality of life. Reference to a study by J. A. Lane et al published in the January 28, 2006 issue of the "British Medical Journal"; Number of patients involved in the study;...

  • EEFECT OF H PYLORI ON QUALITY OF LIFE IN PATIENTS ON LONG TERM PROTON PUMP INHIBITOR THERAPY IN PRIMARY CARE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA78 

    Despite the significant impact on NHS resources due to long term proton pump inhibitor (PPI) prescribing in primary care, little research exists concerning quality of life (QOL) in these patients. Objectives of this study is to ascertain the QOL in patients on long term PPI therapy and determine...

  • The role of Helicobacter pylori infection in functional dyspepsia. Rokkas, Theodore // Annals of Gastroenterology;Apr2012, Vol. 25 Issue 2, p176 

    Eradication of Helicobacter pylori (H. pylori) in patients with functional dyspepsia (FD) continues to be a matter of debate. A recent study [1] examined Helicobacter pylori eradication effects on symptoms and quality of life (QoL) of primary care patients. H. pylori-positive adult patients with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics